| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $708.2 | $696.8 | $951.7 | |
| Short term investments | ||||
| Net receivables | $2799.2 | $2281.8 | $2139.5 | $2148.2 |
| Inventory | $1230.9 | $1132.8 | $1162.4 | $1100.3 |
| Total current assets | $5190.2 | $4884.4 | $4770.4 | $5195.4 |
| Long term investments | $277.3 | $275.3 | $274.4 | |
| Property, plant & equipment | $3115.2 | $2994 | $3038.4 | $2270.9 |
| Goodwill & intangible assets | $559.4 | $579.9 | $601.6 | |
| Total noncurrent assets | $4358.2 | $4318.3 | $4461.2 | |
| Total investments | $277.3 | $275.3 | $274.4 | |
| Total assets | $9720.8 | $9242.6 | $9088.7 | $9656.6 |
| Current liabilities | ||||
| Accounts payable | $1491.4 | $1446.2 | $1361 | $1355.8 |
| Deferred revenue | $1401.7 | $1331.6 | $1485.8 | |
| Short long term debt | $536.7 | $334.4 | $300.2 | |
| Total current liabilities | $4561.9 | $4453.2 | $4128.9 | $4468.6 |
| Long term debt | $715.3 | $1344.7 | $1585.9 | $913.5 |
| Total noncurrent liabilities | $1779.8 | $1914.6 | $2015.9 | |
| Total debt | $1881.4 | $1920.3 | $1969.2 | |
| Total liabilities | $6461.6 | $6233 | $6043.5 | $6519.9 |
| Shareholders' equity | ||||
| Retained earnings | -$4492.7 | -$4726.6 | -$4872.5 | -$4993.1 |
| Other shareholder equity | -$1362.1 | -$1438.3 | -$1326.8 | $3136.7 |
| Total shareholder equity | $2972.4 | $3005.9 | $3136.7 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $951.7 | $1057.1 | $1327.4 | $4807.8 |
| Short term investments | $317.3 | $64.8 | ||
| Net receivables | $2148.2 | $2396.8 | $1877.9 | $3557.4 |
| Inventory | $1100.3 | $1120.5 | $1031.9 | $1268.5 |
| Total current assets | $5195.4 | $4988.7 | $5341.5 | $11444.7 |
| Long term investments | $274.4 | $325 | $292.4 | $358.9 |
| Property, plant & equipment | $2270.9 | $3208.4 | $3357.3 | $3906 |
| Goodwill & intangible assets | $601.6 | $716 | $813.7 | $3493.6 |
| Total noncurrent assets | $4461.2 | $4455.6 | $4678.6 | $8247.9 |
| Total investments | $274.4 | $325 | $609.7 | $358.9 |
| Total assets | $9656.6 | $9444.3 | $10020.1 | $19692.6 |
| Current liabilities | ||||
| Accounts payable | $1355.8 | $1282.8 | $1294.3 | $2740.3 |
| Deferred revenue | $1485.8 | $1156.4 | $1012.9 | $4736.1 |
| Short long term debt | $300.2 | $555.3 | $404.5 | $910.1 |
| Total current liabilities | $4468.6 | $4174.3 | $3851.8 | $10415.2 |
| Long term debt | $913.5 | $1000.7 | $2425.2 | $4198.7 |
| Total noncurrent liabilities | $2015.9 | $1993.3 | $2749.9 | $5019.4 |
| Total debt | $1969.2 | $2291.7 | $2829.7 | $5108.8 |
| Total liabilities | $6519.9 | $6204.1 | $6601.7 | $15434.6 |
| Shareholders' equity | ||||
| Retained earnings | -$4993.1 | -$5010 | -$4903.8 | -$4915.2 |
| Other shareholder equity | $3136.7 | -$1301.7 | -$1305 | -$1622.5 |
| Total shareholder equity | $3136.7 | $3240.2 | $3402.7 | $4154.2 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2348.4 | $2325.6 | $2042 | $2077.7 |
| Cost of revenue | $1824.7 | $1700.6 | ||
| Gross Profit | $493.8 | $500.9 | $341.4 | |
| Operating activities | ||||
| Research & development | $15.2 | $17.6 | ||
| Selling, general & administrative | $174.9 | $159.8 | ||
| Total operating expenses | $202.8 | $192.5 | $182.4 | $1938.8 |
| Operating income | $308.4 | $159 | ||
| Income from continuing operations | ||||
| EBIT | $272.8 | $233.2 | ||
| Income tax expense | -$6 | $59.2 | $49.7 | $54.5 |
| Interest expense | -$7.5 | $27.1 | $26.4 | -$13 |
| Net income | ||||
| Net income | $274.6 | $186.5 | $157.1 | $53 |
| Income (for common shares) | $186.5 | $157.1 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7824.2 | $6700.4 | $6403.5 | $13050.6 |
| Cost of revenue | $5804.1 | $5579.6 | $11209.4 | |
| Gross Profit | $896.3 | $823.9 | $1841.2 | |
| Operating activities | ||||
| Research & development | $67 | $78.4 | $119.8 | |
| Selling, general & administrative | $616.8 | $644.9 | $1066.2 | |
| Total operating expenses | $7315 | $699 | $790 | $4726.8 |
| Operating income | $197.3 | $33.9 | -$2885.6 | |
| Income from continuing operations | ||||
| EBIT | $136.9 | $281.7 | -$2784.6 | |
| Income tax expense | $154.7 | $105.4 | $111.1 | $153.4 |
| Interest expense | -$88.7 | $138.7 | $157.3 | $349.6 |
| Net income | ||||
| Net income | $56.2 | -$107.2 | $13.3 | -$3287.6 |
| Income (for common shares) | -$107.2 | $13.3 | -$3287.6 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $186.5 | $157.1 | ||
| Operating activities | ||||
| Depreciation | $92.1 | $99.5 | ||
| Business acquisitions & disposals | $186.1 | |||
| Stock-based compensation | ||||
| Total cash flows from operations | $230.9 | -$126.7 | ||
| Investing activities | ||||
| Capital expenditures | -$50.8 | -$52 | ||
| Investments | ||||
| Total cash flows from investing | $36.7 | -$49.2 | $136.3 | -$125.6 |
| Financing activities | ||||
| Dividends paid | -$64.7 | -$21.5 | -$21.7 | -$43.5 |
| Sale and purchase of stock | -$100 | -$150.1 | ||
| Net borrowings | -$38 | -$27.4 | ||
| Total cash flows from financing | -$522.5 | -$161.7 | -$256.2 | -$656.5 |
| Effect of exchange rate | -$10.5 | -$8.6 | -$8.3 | -$16.3 |
| Change in cash and equivalents | -$114.2 | $11.4 | -$254.9 | -$105.4 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$107.2 | $13.3 | -$3287.6 | |
| Operating activities | ||||
| Depreciation | $377.2 | $385.4 | $447.2 | |
| Business acquisitions & disposals | $301 | $910.6 | $35.5 | |
| Stock-based compensation | $33.5 | $34.3 | $47.5 | |
| Total cash flows from operations | $352.1 | $781.3 | $656.9 | |
| Investing activities | ||||
| Capital expenditures | -$157.9 | -$191.7 | -$291.8 | |
| Investments | $9.7 | -$1.7 | $29.7 | |
| Total cash flows from investing | -$125.6 | $162.2 | $817.3 | -$180.6 |
| Financing activities | ||||
| Dividends paid | -$43.5 | -$59.2 | ||
| Sale and purchase of stock | -$100.2 | |||
| Net borrowings | -$671.7 | -$1334.1 | -$779.6 | |
| Total cash flows from financing | -$656.5 | -$796.7 | -$5065 | -$1082.2 |
| Effect of exchange rate | -$16.3 | $12.1 | -$14 | $223.5 |
| Change in cash and equivalents | -$105.4 | -$270.3 | -$3480.4 | -$382.4 |
| Market cap | $15.96B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 425.40M |
| Revenue | $8.79B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $671.20M |
| Revenue Q/Q | 14.17% |
| Revenue Y/Y | 18.18% |
| P/E ratio | 23.77 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.81 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.58 |
|---|---|
| ROA | 7.12% |
| ROE | N/A |
| Debt/Equity | 2.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.14 |
| Quick ratio | 0.87 |